Novozymes A/S (OTCMKTS:NVZMF – Get Free Report) is anticipated to issue its resultson Tuesday, May 5th. Analysts expect the company to announce earnings of $0.8880 per share and revenue of $1.3044 billion for the quarter.
Novozymes A/S Price Performance
NVZMF stock opened at $60.81 on Tuesday. Novozymes A/S has a fifty-two week low of $52.10 and a fifty-two week high of $75.97. The business’s 50-day moving average is $57.85 and its two-hundred day moving average is $60.70.
Novozymes A/S Company Profile
Novozymes A/S (OTCMKTS: NVZMF) is a global leader in biological solutions, specializing in the development and production of industrial enzymes and microorganisms. The company’s products are designed to improve the efficiency and sustainability of a wide range of industries, including agriculture, bioenergy, food and beverage, household care, and textiles. By leveraging biotechnology, Novozymes helps customers reduce resource consumption, lower environmental impact, and optimize process performance.
Novozymes offers an extensive portfolio of enzyme products and microbial solutions that address specific industrial challenges such as starch conversion, biofuel production, and ingredient functionality in food processing.
Featured Articles
Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.
